Novel plasma phospholipid biomarkers of autism: Mitochondrial dysfunction as a putative causative mechanism

Élodie Pastural(Phenomenome Discoveries (Canada)), Shawn Ritchie(Phenomenome Discoveries (Canada)), Yingshen Lu(Phenomenome Discoveries (Canada)), Wei Jin(Phenomenome Discoveries (Canada)), Amir Kavianpour(Phenomenome Discoveries (Canada)), Khine Khine Su-Myat(Phenomenome Discoveries (Canada)), Doug Heath(Phenomenome Discoveries (Canada)), Paul L. Wood(Phenomenome Discoveries (Canada)), Maura Fisk, Dayan B. Goodenowe(Phenomenome Discoveries (Canada))

Prostaglandins Leukotrienes and Essential Fatty Acids

July 16, 2009

10.1016/j.plefa.2009.06.003

Cited by 102

Abstract

Related Papers

Epidemiological Surveys of Autism and Other Pervasive Developmental Disorders: An Update

Éric Fombonne|Journal of Autism and Developmental Disorders|2003|1.5k

The epidemiology of autism: a review

Éric Fombonne|Psychological Medicine|1999|985

Epidemiology of autistic disorder and other pervasive developmental disorders.

Éric Fombonne|PubMed|2005|778

The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase.

Anne Voss, Meri Reinhart, Shankar K. Sankarappa et al.|Journal of Biological Chemistry|1991|663

Nontargeted Metabolome Analysis by Use of Fourier Transform Ion Cyclotron Mass Spectrometry

Asaph Aharoni, C. H. Ric De Vos, H. A. Verhoeven et al.|OMICS A Journal of Integrative Biology|2002|423